Pharma Foods International Co., Ltd. (2929.T)
JPY 831.0
(-0.12%)
JPY 831.0
(-0.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 5.11 Billion JPY | 41.63% |
| 2023 | 3.61 Billion JPY | 234.26% |
| 2022 | 1.08 Billion JPY | -80.96% |
| 2021 | 5.67 Billion JPY | 666.6% |
| 2020 | 740.01 Million JPY | 28.42% |
| 2019 | 576.25 Million JPY | 94.4% |
| 2018 | 296.42 Million JPY | 231.44% |
| 2017 | 89.43 Million JPY | 292.96% |
| 2016 | -46.35 Million JPY | 87.54% |
| 2015 | -371.85 Million JPY | -1221.87% |
| 2014 | -28.13 Million JPY | -112.96% |
| 2013 | 217.05 Million JPY | 206.69% |
| 2012 | 70.77 Million JPY | 259.84% |
| 2011 | -44.27 Million JPY | 30.76% |
| 2010 | -63.94 Million JPY | 75.79% |
| 2009 | -264.16 Million JPY | 41.6% |
| 2008 | -452.31 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 601 Million JPY | -69.59% |
| 2024 Q4 | 1.84 Billion JPY | 6.7% |
| 2024 Q2 | 934 Million JPY | 55.41% |
| 2024 Q3 | 1.73 Billion JPY | 85.33% |
| 2023 FY | 3.61 Billion JPY | 234.26% |
| 2023 Q2 | 1.31 Billion JPY | 159.78% |
| 2023 Q4 | 1.97 Billion JPY | -21.49% |
| 2023 Q1 | -2.19 Billion JPY | -1571.81% |
| 2023 Q3 | 2.51 Billion JPY | 91.99% |
| 2022 Q4 | 149 Million JPY | 113.53% |
| 2022 FY | 1.08 Billion JPY | -80.96% |
| 2022 Q3 | -1.1 Billion JPY | -340.92% |
| 2022 Q2 | 457 Million JPY | -70.98% |
| 2022 Q1 | 1.57 Billion JPY | -48.19% |
| 2021 Q2 | 1.34 Billion JPY | 194.27% |
| 2021 FY | 5.67 Billion JPY | 666.6% |
| 2021 Q4 | 3.03 Billion JPY | 11.98% |
| 2021 Q3 | 2.71 Billion JPY | 101.57% |
| 2021 Q1 | -1.42 Billion JPY | -243.26% |
| 2020 FY | 740.01 Million JPY | 28.42% |
| 2020 Q4 | 997.26 Million JPY | -24.92% |
| 2020 Q3 | 1.32 Billion JPY | 265.91% |
| 2020 Q1 | -784.88 Million JPY | -212.66% |
| 2020 Q2 | -800.57 Million JPY | -2.0% |
| 2019 Q2 | 103.02 Million JPY | 126.34% |
| 2019 FY | 576.25 Million JPY | 94.4% |
| 2019 Q4 | 696.68 Million JPY | 315.44% |
| 2019 Q1 | -391.15 Million JPY | -173.1% |
| 2019 Q3 | 167.69 Million JPY | 62.77% |
| 2018 Q4 | 535.11 Million JPY | -14.17% |
| 2018 Q2 | -379.14 Million JPY | 21.51% |
| 2018 Q1 | -483.02 Million JPY | -270.45% |
| 2018 FY | 296.42 Million JPY | 231.44% |
| 2018 Q3 | 623.47 Million JPY | 264.44% |
| 2017 Q3 | 303.61 Million JPY | 617.15% |
| 2017 FY | 89.43 Million JPY | 292.96% |
| 2017 Q4 | 283.38 Million JPY | -6.66% |
| 2017 Q2 | -58.7 Million JPY | 86.62% |
| 2017 Q1 | -438.85 Million JPY | -251.81% |
| 2016 FY | -46.35 Million JPY | 87.54% |
| 2016 Q2 | -67.5 Million JPY | 81.96% |
| 2016 Q1 | -374.21 Million JPY | -8807.74% |
| 2016 Q3 | 106.28 Million JPY | 257.46% |
| 2016 Q4 | 289.07 Million JPY | 171.97% |
| 2015 Q3 | -129.18 Million JPY | -148.45% |
| 2015 Q2 | -51.99 Million JPY | 72.12% |
| 2015 Q1 | -186.47 Million JPY | -263.36% |
| 2015 FY | -371.85 Million JPY | -1221.87% |
| 2015 Q4 | -4.2 Million JPY | 96.75% |
| 2014 Q4 | 114.14 Million JPY | 190.54% |
| 2014 Q1 | 1.47 Million JPY | -98.89% |
| 2014 FY | -28.13 Million JPY | -112.96% |
| 2014 Q2 | -17.67 Million JPY | -1302.04% |
| 2014 Q3 | -126.08 Million JPY | -613.53% |
| 2013 FY | 217.05 Million JPY | 206.69% |
| 2013 Q1 | 60.06 Million JPY | -59.06% |
| 2013 Q2 | 7.96 Million JPY | -86.74% |
| 2013 Q3 | 16.18 Million JPY | 103.19% |
| 2013 Q4 | 132.85 Million JPY | 721.08% |
| 2012 Q4 | 146.71 Million JPY | 1313.4% |
| 2012 FY | 70.77 Million JPY | 259.84% |
| 2012 Q2 | -29.64 Million JPY | 13.33% |
| 2012 Q3 | -12.09 Million JPY | 59.21% |
| 2012 Q1 | -34.2 Million JPY | -187.7% |
| 2011 Q2 | -15.97 Million JPY | 76.63% |
| 2011 FY | -44.27 Million JPY | 30.76% |
| 2011 Q4 | 38.99 Million JPY | 4399.67% |
| 2011 Q3 | -907 Thousand JPY | 94.32% |
| 2011 Q1 | -68.32 Million JPY | -2034.61% |
| 2010 Q2 | 7.07 Million JPY | 111.54% |
| 2010 FY | -63.94 Million JPY | 75.79% |
| 2010 Q1 | -61.29 Million JPY | 21.98% |
| 2010 Q4 | -3.2 Million JPY | 78.92% |
| 2010 Q3 | -15.18 Million JPY | -314.65% |
| 2009 Q4 | -78.57 Million JPY | -16.34% |
| 2009 Q3 | -67.53 Million JPY | -26.86% |
| 2009 Q1 | -68.56 Million JPY | 0.0% |
| 2009 FY | -264.16 Million JPY | 41.6% |
| 2009 Q2 | -53.23 Million JPY | 22.36% |
| 2008 FY | -452.31 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 97.612% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 101.444% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 97.018% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 2715.198% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 83.709% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | 46.252% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 90.427% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -614.106% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | 61.168% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | 11.89% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -160.336% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 1135.02% |
| Tsumura & Co. | 20.01 Billion JPY | 74.458% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -27.284% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -1.529% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 71.028% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -32.53% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | 47.379% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | 14.968% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 266.06% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -31.305% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 729.937% |
| MedRx Co., Ltd | -933 Million JPY | 648.017% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | 0.757% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 548.903% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 315.738% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | 21.338% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 72.927% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 833.113% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 73.55% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -16.673% |